Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a cancer center to […]
News: Breast CancerNext Page »
Nashville (Tenn.) – Vanderbilt LifeFlight is going pink during October to show its support for breast cancer awareness.LifeFlight medical crews will wear a special pink name badge on their flight suits and other staff will wear pink golf shirts. October is designated as National Breast Cancer Awareness Month, dedicated to raising awareness and educating individuals […]
Overcoming therapeutic resistance that inevitably develops is one of the major challenges in treating lung cancer. Non-small cell lung cancers that harbor mutations in the epidermal growth factor receptor (EGFR) are initially responsive to targeted therapies known as EGFR tyrosine kinase inhibitors (TKIs). However, most patients eventually develop resistance to these therapies. One such targeted […]
Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered. The studies, reported July 17 in PLoS Biology, demonstrate in mice that activation of the sympathetic nervous system – the “fight-or-flight” response to stress – primes the bone environment for breast cancer cell metastasis. The researchers were able […]
Three cancer survivors share their story of what their life looks like on the other side of cancer. Learn more at http://www.VanderbiltCancerWellness.com or call 1 (877) 936-8422 for an appointment.
The Vanderbilt Breast Center is hosting “Girls’ Day Out,” an event that offers women a chance to enjoy good food and pampering while they prepare for an annual breast cancer screening mammogram. The event is Saturday, June 23, from 10 a.m. to 1 p.m., at the Vanderbilt Breast Center, suite 25000 at Vanderbilt Health One […]
A breast cancer patient who has enrolled in two clinical research trials at Vanderbilt-Ingram Cancer Center was the only presenter to receive a standing ovation during a recent Stand Up To Cancer (SU2C) news briefing at the American Association for Cancer Research (AACR) annual meeting in Chicago. Jeanette Daniel, 51, a metastatic breast cancer patient, […]
A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. The study by lead author Justin Balko, Pharm.D., Ph.D., was published online June 10, 2012 […]
Justin Balko, Pharm.D., Ph.D., was named Vanderbilt-Ingram Cancer Center’s Postdoctoral Fellow of the Year. He describes some of his breast cancer research pertaining to drug resistance and targeted therapeutics. He also notes the exceptional translational research environment that Vanderbilt provides. Balko is a researcher in the Carlos Arteaga lab.
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology, associate director of Clinical Research and director of the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center, has been awarded a five-year Clinical Research Professorship grant from the American Cancer Society (ACS). The $400,000 award is a renewal of a previous grant to Arteaga in 2007 […]